One exemplar protein of this metabolic pathway enrichment, enolase 1 (ENO1), converts 2-phosphoglycerate to phosphoenolpyruvate and serves as a cell surface receptor for plasminogen [63], where it is potentially involved in prostate cancer cell migration [64]. This evidence concerns the gene CD177 and prostate cancer.